(Q40772396)

23 September 2017

title

Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset (English)

1 reference

23 September 2017

main subject

restless legs syndrome

1 reference

1 reference

2

Earley CJ

1 reference

23 September 2017

1

Allen RP

1 reference

23 September 2017

publication date

1 February 2000

1 reference

23 September 2017

number of pages

9

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

23 September 2017

volume

1

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

11-19

1 reference

A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Iron status and restless legs syndrome in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Augmentation of the restless legs syndrome with carbidopa/levodopa.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Variable expressivity in familial restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

Restless legs syndrome: clinicoetiologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900012-X

7 January 2021

10.1016/S1389-9457(99)00012-X

Identifiers

DOI

1 reference

23 September 2017

1 reference